Leaders of federally qualified clinics and safety-net hospitals joined local politicians to highlight what they say is a ...

To add insult to injury, many hospitals that aggressively pursue unpaid medical bills profit from a federal drug discount program: the 340B Drug Pricing Program, which was established to help ...

Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of ...

The time has come to pass legislation to mandate enforceable price transparency and "site neutral" payments, as well as ban ...

Amgen Inc (AMGN) reports robust sales growth with 14 blockbuster products, while navigating competitive pressures and strategic pivots.

Novo Nordisk’s 2026 outlook reflects this shift with an adjusted basis excluding the non-recurring reversal of $4.2 billion in 340B Drug Pricing Program rebate provisions. 1 Sales and operating profit ...

Centurion Foundation hopes to close on the sale of Roger Williams Medical Center and Fatima Hospital by the end of February ...

Amgen is running a number of studies of its obesity drug, MariTide.

For nearly four years, The Centurion Foundation CEO Ben Mingle has argued the nonprofit would be the best steward of Roger ...

Novo Nordisk (NVO) stock falls after issuing weak outlook for 2026 due to pricing pressure and competition. Q4 earnings beat.

Regional and remote airports impacted by Rex’s administration can apply for reimbursement from a pool of $5 million under the ...